Observational studyCritical care medicine2013
Predictors of 30-day readmission after intracerebral hemorrhage: a single-center approach for identifying potentially modifiable associations with readmission.
Observational study in Critical care medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Trial
- Changes in Cerebral Blood Flow and Diffusion-Weighted Imaging Lesions After Intracerebral Hemorrhage.Translational stroke research · 2022Review
- Review
- TASC (Telehealth After Stroke Care): a study protocol for a randomized controlled feasibility trial of telehealth-enabled multidisciplinary stroke care in an underserved urban setting.Pilot and feasibility studies · 2022Article
- Risk of Mortality After an Arterial Ischemic Event Among Intracerebral Hemorrhage Survivors.The Neurohospitalist · 2022Article
- Predicting 30-Day Readmission for Stroke Using Machine Learning Algorithms: A Prospective Cohort Study.Frontiers in neurology · 2022Article
- Patient Characteristics Associated With Readmission to 3 Neurology Services at an Urban Academic Center.The Neurohospitalist · 2021Article
- Evaluation of the Accuracy of Standard Renal Function Equations in Critically Ill Patients with Subarachnoid Hemorrhage.Neurocritical care · 2020Observational
- Article
- Article
- Enhanced renal clearance and impact on vancomycin pharmacokinetic parameters in patients with hemorrhagic stroke.Journal of intensive care · 2019Article
- Risk factors associated with 31-day unplanned readmission in 50,912 discharged patients after stroke in China.BMC neurology · 2018Article
- Depressive symptom prevalence after intracerebral hemorrhage: a multi-center study.Journal of patient-reported outcomes · 2018Article
- Thirty-day readmission after spontaneous intracerebral hemorrhage.Brain and behavior · 2018Article
- Predictors of 30-day readmission after aneurysmal subarachnoid hemorrhage: a case-control study.Journal of neurosurgery · 2017Article
- High Mortality among 30-Day Readmission after Stroke: Predictors and Etiologies of Readmission.Frontiers in neurology · 2017Article
- Vancomycin Pharmacokinetic Parameters in Patients with Hemorrhagic Stroke.Neurocritical care · 2016Article
- Majority of 30-Day Readmissions After Intracerebral Hemorrhage Are Related to Infections.Stroke · 2016Observational
- From discharge planner to "concierge": recommendations for hospital social work by clients with intracerebral hemorrhage.Social work in public health · 2015Article
Corrections and comments
- Commented on by
Authors and funding
10 authors.
Funding
Abstract
objectiveTo determine whether patient's demographics or severity of illness predict hospital readmission within 30 days following spontaneous intracerebral hemorrhage, to identify readmission associations that may be modifiable at the single-center level, and to determine the impact of readmission on outcomes.
designWe collected demographic, clinical, and hospital course data for consecutive patients with spontaneous intracerebral hemorrhage enrolled in an observational study. Readmission within 30 days was determined retrospectively by an automated query with manual confirmation. We identified the reason for readmission and tested for associations between readmission and functional outcomes using modified Rankin Scale (a validated functional outcome measure from 0, no symptoms, to 6, death) scores before intracerebral hemorrhage and at 14 days, 28 days, and 3 months after intracerebral hemorrhage.
settingNeurologic ICU of a tertiary care hospital. PATIENTS: Critically ill patients with spontaneous intracerebral hemorrhage.
interventionsPatients received standard critical care management for intracerebral hemorrhage. MEASUREMENTS AND MAIN
resultsOf 246 patients (mean age, 65 yr; 51% female), 193 patients (78%) survived to discharge. Of these, 22 patients (11%) were readmitted at a median of 9 days (interquartile range, 4-15 d). The most common readmission diagnoses were infections after discharge (n = 10) and vascular events (n = 6). Age, history of stroke and hypertension, severity of neurologic deficit at admission, Acute Physiology and Chronic Health Evaluation score, ICU and hospital length of stay, ventilator-free days, days febrile, and surgical procedures were not predictors of readmission. History of coronary artery disease was associated with readmission (p = 0.03). Readmitted patients had similar modified Rankin Scale and severity of neurologic deficit at 14 days but higher (worse) modified Rankin Scale scores at 3 months (median [interquartile range], 5 [3-6] vs 3 [1-4]; p = 0.01).
conclusionsSeverity of illness and hospital complications were not associated with 30-day readmission. The most common indication for readmission was infection after discharge, and readmission was associated with worse functional outcomes at 3 months. Preventing readmission after intracerebral hemorrhage may depend primarily on optimizing care after discharge and may improve functional outcomes at 3 months.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.